token	BIEO	IOB2
Human	B-virus	B-virus
papillomavirus	E-virus	I-virus
(	O	O
HPV	B-virus	B-virus
)	O	O
common	O	O
sexually	O	O
transmitted	O	O
viral	O	O
infection	O	O
.	O	O
		
Infection	O	O
certain	O	O
types	O	O
HPV	B-virus	B-virus
pose	O	O
major	O	O
public	O	O
health	O	O
risk	O	O
types	O	O
associated	O	O
multiple	O	O
human	O	O
cancers	O	O
,	O	O
including	O	O
cervical	O	O
cancer	O	O
,	O	O
anogenital	O	O
malignancies	O	O
increasing	O	O
number	O	O
head	O	O
neck	O	O
cancers	O	O
.	O	O
		
The	O	O
HPV	B-virus	B-virus
life	O	O
cycle	O	O
closely	O	O
tied	O	O
host	O	O
cell	O	O
differentiation	O	O
late	O	O
viral	O	O
events	O	O
structural	O	O
gene	O	O
expression	O	O
viral	O	O
genome	O	O
amplification	O	O
taking	O	O
place	O	O
upper	O	O
layers	O	O
stratified	O	O
epithelium	O	O
.	O	O
		
The	O	O
DNA	O	O
damage	O	O
response	O	O
(	O	O
DDR	O	O
)	O	O
elaborate	O	O
signaling	O	O
network	O	O
proteins	O	O
regulate	O	O
fidelity	O	O
replication	O	O
detecting	O	O
,	O	O
signaling	O	O
repairing	O	O
DNA	O	O
lesions	O	O
.	O	O
		
ATM	O	O
ATR	O	O
two	O	O
kinases	O	O
major	O	O
regulators	O	O
DNA	O	O
damage	O	O
detection	O	O
repair	O	O
.	O	O
		
A	O	O
multitude	O	O
studies	O	O
indicate	O	O
activation	O	O
ATM	O	O
(	O	O
Ataxia	O	O
telangiectasia	O	O
mutated	O	O
)	O	O
ATR	O	O
(	O	O
Ataxia	O	O
telangiectasia	O	O
Rad3-related	O	O
)	O	O
pathways	O	O
critical	O	O
HPV	B-virus	B-virus
productively	O	O
replicate	O	O
.	O	O
		
This	O	O
review	O	O
outlines	O	O
HPV	B-virus	B-virus
interfaces	O	O
ATM-	O	O
ATR-dependent	O	O
DNA	O	O
damage	O	O
responses	O	O
throughout	O	O
viral	O	O
life	O	O
cycle	O	O
create	O	O
environment	O	O
supportive	O	O
viral	O	O
replication	O	O
activation	O	O
pathways	O	O
could	O	O
impact	O	O
genomic	O	O
stability	O	O
.	O	O
